The tariff classification of Glucose Dehydrogenase “Amano” 8 from Japan
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the GDH-8 will be 3507.90.7080, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Enzymes; prepared enzymes not elsewhere specified or included: Other: Other: Other.” The general rate of duty will be free.
Ruling text
In your letter dated August 26, 2026, on behalf of Amano Enzyme U.S.A. Co. Ltd., you requested a tariff classification ruling. The product under consideration is Glucose Dehydrogenase “Amano” 8 (GDH-8), imported in bulk for use in the manufacture of blood glucose test strips. GDH-8 is a unique and specially formulated microbial enzyme, also known as glucose 1-dehydrogenase, with CAS No. 37250-84-3. It is the key ingredient in the chemical solution used in the manufacture of blood glucose test strips.
These test strips are designed for use only with a specific self-monitoring blood glucose meter system (Blood Glucose Meter). They are inserted into the system, after which blood is drawn into the monitor’s sample tip and the blood sample comes into contact with the test strip in the sample tip.
The GDH-8 on the test strip oxidizes glucose from the blood sample, creating a redox reaction that releases electrons, allowing the mediator to carry electrons to the electrode, which creates a tiny electrical current that can be read by the meter. The GDH-8 is responsible for this electron-transfer chain that provides the glucose sensing, which is the essential function of a blood glucose meter or monitor for diabetic care.
You claim that while glucose dehydrogenase has other limited industrial applications in the marketplace, the subject GDH-8 does not. You further state that the GDH-8 enzyme is the critical component of the test strip because it reacts with the blood to detect the glucose level that is read by the meter.
Without the GDH-8, the test strip could not react with the blood to detect the glucose, and the meter could not read the glucose level to inform the patient and thus perform the key function of the Blood Glucose Meter. The applicable subheading for the GDH-8 will be 3507.90.7080, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Enzymes; prepared enzymes not elsewhere specified or included: Other: Other: Other.” The general rate of duty will be free.
In your submission you requested consideration of a secondary classification under 9817.00.96, HTSUS, which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “Articles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: Other.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N364610).